Brainstorm announces second quarter 2021 financial results and provides a corporate update

New york, aug. 5, 2021 /prnewswire/ -- brainstorm cell therapeutics inc. (nasdaq: bcli), a leading developer of cellular therapies for neurodegenerative diseases, announced today financial results for the first quarter ended june 30, 2021 and provided a corporate update. "we continue to take important steps to advance nurown in als and progressive ms and position ourselves for sustained success," said chaim lebovits, chief executive officer of brainstorm.
BCLI Ratings Summary
BCLI Quant Ranking